Frequency and outcomes of new suspicious lesions on breast MRI in neoadjuvant therapy

During neoadjuvant chemotherapy, new suspicious findings detected on breast magnetic resonance imaging (MRI) during neoadjuvant therapy are most likely benign, according to a study to be presented at the ARRS 2019 Annual Meeting, set for May 5-10 in Honolulu, Hawaii.
Source: EurekaAlert,